Form 4 for HCA HCA Healthcare
Accepted 2023-04-14 00:00:00 ET · period of report 2023-04-12 · accession 0001209191-23-024369 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-14 | 2023-04-12 | HCA | Paslick P. Martin | SVP, CIO | M - OptEx | $81.96 | +6,340 | 31.0K | +26% | +$519.6K |
| D | 2023-04-14 | 2023-04-14 | HCA | Paslick P. Martin | SVP, CIO | S - Sale+OE | $275.00 | -2,687 | 24.6K | -10% | -$738.9K |
| D | 2023-04-14 | 2023-04-12 | HCA | Paslick P. Martin | SVP, CIO | F - Tax | $272.38 | -3,653 | 27.3K | -12% | -$995.0K |
| D | 2023-04-14 | 2023-04-12 | HCA | Paslick P. Martin | SVP, CIO | M - OptEx | $0.00 | -6,340 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-12 | M | A | 6,340 | $81.96 | 30,983 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-14 | S | D | 2,687 | $275.00 | 24,643 | D | — | — | |
| 3 | Common | Common Stock | 2023-04-12 | F | D | 3,653 | $272.38 | 27,330 | D | — | — | |
| 4 | Derivative | Stock Appreciation Right | 2023-04-12 | M | D | 6,340 | $0.00 | 0 | D | $81.96 · — to 2027-02-01 | 6,340 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. |